We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+21.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.33B
AUM Growth
+$2.19B
Cap. Flow
+$2.21B
Cap. Flow %
50.99%
Top 10 Hldgs %
9.94%
Holding
1,042
New
377
Increased
333
Reduced
160
Closed
123

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$43.5M
2
WMT icon
Walmart Inc
WMT
+$42.1M
3
PCAR icon
PACCAR
PCAR
+$42M
4
CHRD icon
Chord Energy
CHRD
+$41.4M
5
ADBE icon
Adobe
ADBE
+$38.4M

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$30.3M
2
BA icon
Boeing
BA
+$29.4M
3
CF icon
CF Industries
CF
+$15M
4
EXAS
Exact Sciences
EXAS
+$12.9M
5
XEL icon
Xcel Energy
XEL
+$10.8M

Sector Composition

Rank Sector Weight
1 Industrials 17.38%
2 Technology 13.64%
3 Healthcare 13.3%
4 Financials 11.71%
5 Consumer Discretionary 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSGR icon
951
Distribution Solutions Group
DSGR
$1.61B
-7,014
Closed -$249K
DT icon
952
Dynatrace
DT
$14.3B
-102,038
Closed -$4.74M
EIX icon
953
Edison International
EIX
$26.7B
-19,303
Closed -$1.37M
ELS icon
954
Equity Lifestyle Properties
ELS
$12.4B
-6,200
Closed -$399K
ESPR
955
DELISTED
Esperion Therapeutics
ESPR
-166,457
Closed -$446K
EXAS
956
DELISTED
Exact Sciences
EXAS
-186,358
Closed -$12.9M
EXP icon
957
Eagle Materials
EXP
$6.47B
-8,071
Closed -$2.19M
FFIV icon
958
F5
FFIV
$24B
-2,300
Closed -$436K
FLGT icon
959
Fulgent Genetics
FLGT
$515M
-9,816
Closed -$213K
FNB icon
960
FNB Corp
FNB
$6.86B
-42,553
Closed -$600K
FTV icon
961
Fortive
FTV
$18.6B
-55,948
Closed -$3.63M
FUTU icon
962
Futu Holdings
FUTU
$14.7B
-13,800
Closed -$747K
HAYW icon
963
Hayward Holdings
HAYW
$3.25B
-16,200
Closed -$248K
HRTX icon
964
Heron Therapeutics
HRTX
$64.7M
-11,727
Closed -$32.5K
INFA
965
DELISTED
Informatica
INFA
-18,550
Closed -$649K
JBLU icon
966
JetBlue
JBLU
$2.18B
-112,297
Closed -$833K
JLL icon
967
Jones Lang LaSalle
JLL
$16.7B
-3,640
Closed -$710K
JMIA
968
Jumia Technologies
JMIA
$793M
-103,059
Closed -$528K
KLXE icon
969
KLX Energy Services
KLXE
$35.1M
-17,970
Closed -$139K
KOP icon
970
Koppers
KOP
$857M
-12,171
Closed -$671K
KURA icon
971
Kura Oncology
KURA
$882M
-23,754
Closed -$507K
MZTI
972
The Marzetti Company
MZTI
$3.18B
-4,182
Closed -$868K
LEGN icon
973
Legend Biotech
LEGN
$4B
-34,746
Closed -$1.95M
LHX icon
974
L3Harris
LHX
$54.1B
-19,600
Closed -$4.18M
LMND icon
975
Lemonade
LMND
$4B
-29,090
Closed -$477K

Similar funds

Susquehanna Fundamental Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Susquehanna Fundamental Investments held 1,042 positions worth $4.33B, up 102% from $2.14B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Susquehanna Fundamental Investments deployed $2.21B of net new capital in Q2 2024, opening 377 new positions and adding to 333 existing holdings. Its largest new stake was Bristol-Myers Squibb: 972,243 shares worth $40.4M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Boeing, an estimated $29.4M trimmed.

  • Susquehanna Fundamental Investments's largest Q2 2024 buy was Bristol-Myers Squibb: 972,243 shares worth $40.4M.
  • Susquehanna Fundamental Investments added most to Chord Energy in Q2 2024, an estimated $41.4M increase.
  • Susquehanna Fundamental Investments's biggest Q2 2024 reduction was Boeing, cutting an estimated $29.4M.
  • Susquehanna Fundamental Investments fully exited US Bancorp in Q2 2024, selling an estimated $30.3M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 9.9% of its $4.33B portfolio in Q2 2024.
  • Susquehanna Fundamental Investments opened 377 new positions and closed 123 in Q2 2024.
  • Susquehanna Fundamental Investments's portfolio value rose 102% quarter-over-quarter to $4.33B.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.